Scotland’s National Health Service saw a dramatic increase in the prescription of semaglutide, known commercially as Ozempic and Wegovy, as the annual number of prescriptions rose to 168,486 in 2024
Obesity
3Articles
The UK market for private weight loss drugs is bracing itself for seismic change as Eli Lilly announces dramatic price increases for its popular Mounjaro injections. Over 1.5 million Britons
The American pharmaceutical giant Pfizer has discontinued the development of its experimental weight-loss pill following safety concerns, marking a significant setback in its pursuit of the lucrative anti-obesity market, estimated